Skip to main content

and
  1. No Access

    Article

    The association of smoking with urinary and sexual function recovery following radical prostatectomy for localized prostate cancer: a systematic review and meta-analysis

    Urinary and sexual dysfunction after radical prostatectomy remains a major cause of morbidity, despite widespread availability of pharmacological and rehabilitative treatments. Smoking is a modifiable risk fac...

    Jordi Visscher, Mrunal Hiwase, Billie Bonevski in Prostate Cancer and Prostatic Diseases (2024)

  2. Article

    Open Access

    Length of positive surgical margins after radical prostatectomy: Does size matter? – A systematic review and meta-analysis

    The prognostic capacity of positive surgical margins (PSM) for biochemical recurrence (BCR) is unclear, with inconsistent findings across published studies. We aimed to systematically review and perform a meta...

    Athul John, Alicia Lim, Rick Catterwell in Prostate Cancer and Prostatic Diseases (2023)

  3. Article

    Open Access

    Responsiveness and construct validity of EPIC-26, AQoL-6D and SF-6D following treatment in prostate cancer

    To assess construct validity and responsiveness of the Expanded Prostate Cancer Index Composite Instrument (EPIC-26) relative to the Short-Form Six-Dimension (SF-6D) and Assessment of Quality of Life 6-Dimensi...

    Norma B. Bulamu, Christine Mpundu-Kaambwa, Michael O’Callaghan in BMC Cancer (2023)

  4. Article

    Open Access

    Evaluation of selective bone scan staging in prostate cancer – external validation of current strategies and decision-curve analysis

    Recommendations for staging newly diagnosed prostate cancer patients vary between guidelines and literature.

    Mrunal D. Hiwase, Alex Jay, Norma Bulamu in Prostate Cancer and Prostatic Diseases (2022)

  5. No Access

    Article

    Prostate cancer detection: a systematic review of urinary biosensors

    Current diagnostic methods for prostate cancer are invasive and lack specificity towards aggressive forms of the disease, which can lead to overtreatment. A new class of non-invasive alternatives is under deve...

    Kit Man Chan, Jonathan M. Gleadle in Prostate Cancer and Prostatic Diseases (2022)

  6. No Access

    Article

    Prognostic Differences in ISUP Grade Group 4: a Systematic Review and Meta-Analysis

    The ISUP (Internal Society of Urologic Pathology) recently adopted a five-tiered prognostication system. There is evidence to suggest that the ISUP grade group 4 is a heterogeneous entity regarding prognosis. ...

    Thomas Chengxuan Lu, Luke Collins, Penelope Cohen in Pathology & Oncology Research (2020)

  7. No Access

    Article

    ISUP Group 4 – a Homogenous Group of Prostate Cancers?

    The International Society of Urological Pathology (ISUP) and the World Health Organisation have adopted a five-tiered prognostic grade group for prostate cancer in 2014. Grade group 4 is comprised of Gleason p...

    Thomas Chengxuan Lu, Kim Moretti, Kerri Beckmann in Pathology & Oncology Research (2018)

  8. Article

    Open Access

    A retrospective analysis of Victorian and South Australian clinical registries for prostate cancer: trends in clinical presentation and management of the disease

    Prostate cancer (PCa) is the most commonly diagnosed malignancy reported to Australian cancer registries with numerous studies from individual registries summarizing diagnostic and treatment characteristics. T...

    Rasa Ruseckaite, Kerri Beckmann, Michael O’Callaghan, David Roder in BMC Cancer (2016)

  9. Article

    Open Access

    Development of South Australian-Victorian Prostate Cancer Health Outcomes Research Dataset

    Prostate cancer is the most commonly diagnosed and prevalent malignancy reported to Australian cancer registries, with numerous studies from single institutions summarizing patient outcomes at individual hospi...

    Rasa Ruseckaite, Kerri Beckmann, Michael O’Callaghan, David Roder in BMC Research Notes (2016)